期刊文献+

金米益肺汤对非小细胞肺癌患者血清VEGF表达的影响 被引量:4

Effect of Jinmi Decoction on Concentration of Serum Vascular Endothelial Growth Factor in Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的研究金米益肺汤对非小细胞肺癌患者血清中VEGF水平的影响,并探讨其抗肿瘤作用机制。方法将60例非小细胞肺癌患者随机分为联合治疗组与化疗组,联合治疗组采用金米益肺汤联合化疗,化疗组采用单纯化疗,应用ELISA法测定两组患者治疗前后及20例健康体检人员血清中VEGF的表达。结果非小细胞肺癌患者血清中VEGF表达为(389.45±80.23)pg/ml,明显高于健康对照组(97.67±42.63)pg/ml,差异有统计学意义(P<0.01)。治疗后检测联合治疗组血清VEGF表达为(231.52±83.91)pg/ml,低于单纯化疗组(295.17±76.43)pg/ml,差异有统计学意义(P<0.05)。结论金米益肺汤可显著降低非小细胞肺癌患者血清VEGF的表达,提示金米益肺汤具有抗肿瘤血管形成作用。 Objective To investigate the effects of Jinmi decoction on the serum vascular endothelial growth factor(VEGF) in non-small cell lung cancer and its anti-tumor mechanism.Methods Sixty cases of non-small cell lung cancer were randomly divided into combination therapy group(Jinmi decoction + chemotherapy) and chemotherapy group.The serum VEGF concentration was detected by ELISA in the two groups and in 20 normal controls.Results The serum VEGF concentration in non-small cell lung cancer was(389.45±80.23)pg/ml,higher than that in normal controls(P0.01).The concentration of serum VEGF after therapy in combination therapy group was significantly lower than that in chemotherapy group(231.52±83.91)pg/ml vs..(295.17±76.43)pg/ml,(P0.05).Conclusion Jinmi decoction could obviously reduce the concentration of serum VEGF and inhibit tumor angiogenesis in non-small cell lung cancer.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第5期567-569,共3页 Cancer Research on Prevention and Treatment
关键词 金米益肺汤 非小细胞肺癌 血管内皮生长因子 Jinmi decoction Non-small cell lung cancer VEGF
  • 相关文献

参考文献12

  • 1陈建,纪钧,陈大可,等.肿瘤临床应对策略[M].南京:南京大学出版社,2010:79.
  • 2纪钧,蔡忠仁,陈大可,黎辰,陈勇,纪易斐,单桂芹,张莉,顾建建,钱滨滨.金米益肺汤配合化疗治疗非小细胞肺癌及对生活质量的影响[J].陕西中医,2010,31(4):387-388. 被引量:13
  • 3Yilmaz A,Emam D,Unsal E,et al. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung caneer[J]. Arch Med Res, 2007,38(7):764-8.
  • 4Yoo J, Jung JH, Lee MA, et al. Immunohistochemical analysis of non-small cell lung cancer.-correlation with clinical parame- ters and prognosis[J]. J Korean Med Sci,2007,22(2):318-25.
  • 5Ho QT, Kuo CJ. Vascular endothelial growth factor: Biology and therapectic applications[J]. Int J Biochem Cell Biol, 2007, 39(7-8) : 1349-57.
  • 6Mcdonnell CO, Hill AD, Mcnamara DA, et al. Tumor microme- tastases:the influence of angiohenesis[J]. Eur J Surg Oncol, 2000,26(2): 105-15.
  • 7姜昕,周建华,邓征浩,屈晓辉,蒋海鹰,刘英.非小细胞肺癌中Notch1、HIF-1、VEGF蛋白及Notch1 mRNA的表达及意义[J].临床与实验病理学杂志,2008,24(3):276-279. 被引量:22
  • 8Seto T, Higashiyama M, Funai H, et al. Prognostic value of ex- pression of vascular endothelial growth factorand its flt-1 and KDR receptors in stage I non-small cell lung cancer[J]. Lung Cancer, 2006,53 ( 1 ) : 91-6.
  • 9Mineo TC, Ambrogi V, Baldi A, et al. Prognostic impact VEGF, CD31,CD34,and CD105 expression and tumor vessel invasion after radical surgery for IB-IIA non-small cell lung cancer[J]. J Clin Pathol, 2004,57 (6) : 591-7.
  • 10Shimanuki Y,Takahashi K,Cui R,et al. Role of serum vascu- lar endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer[J]. Lung, 2005, 183(1) :29-42.

二级参考文献23

共引文献38

同被引文献49

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部